Tempus AI (NASDAQ: TEM ) is rated as a ‘Buy’ for long-term growth-oriented profiles. Tempus AI is progressively transitioning from a diagnostics provider into a leader in data and AI platforms for precision oncology. Its flywheel model is now observableAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not rec ...